Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Direxion Daily S&P 500 Bear 3X Shares ETF
SPXS
5
T-Rex 2x Inverse Tesla Daily Target ETF
TSLZ
US Stock MarketDetailed Quotes
MGTX MeiraGTx Holdings
- 6.810
- +0.110+1.64%
Close Apr 28 16:00 ET
- 6.760
- -0.050-0.73%
Pre 06:15 ET
537.00MMarket Cap-3.21P/E (TTM)
6.830High6.530Low363.06KVolume6.710Open6.700Pre Close2.43MTurnover1.16%Turnover RatioLossP/E (Static)78.85MShares8.75052wk High7.92P/B213.21MFloat Cap3.85052wk Low--Dividend TTM31.31MShs Float30.230Historical High--Div YieldTTM4.48%Amplitude3.490Historical Low6.692Avg Price1Lot Size
About MeiraGTx Holdings Company
MeiraGTx Holdings Plc engages in the development of novel gene therapy treatments. It focuses on the development and manufacturing of genetic medicines to treat both inherited and more common conditions with severe unmet need. The company was founded on March 20, 2015 and is headquartered in New York, NY.
Company Profile
SymbolMGTX
Company NameMeiraGTx Holdings
Listing DateJun 8, 2018
Issue Price15.00
Founded2018
CEODr. Alexandria Forbes, PhD
MarketNASDAQ
Employees425
Fiscal Year Ends12-31
Address450 East 29th Street,14th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10016
Phone1-646-860-7985
Websitehttp://www.meiragtx.com
Company Executives
- Name
- Position
- Salary
- Dr. Alexandria Forbes, PhD
- President, Chief Executive Officer and Director
- 6.34M
- Dr. Stuart Naylor, PhD
- Chief Development Officer
- 2.50M
- Dr. Robert K. Zeldin, M.D.
- Chief Medical Officer
- --
- Richard Giroux
- Chief Accounting Officer, Chief Operating Officer and Chief Financial Officer
- 4.98M
- Dr. Keith R. Harris, PhD
- Chairman of the Board
- 538.84K
- Dr. Ellen Hukkelhoven, PhD
- Director
- 264.23K
- Ambassador Martin Indyk, PhD
- Independent Director
- 340.23K
- Nicole Seligman
- Independent Director
- 395.76K
- Lord Neil Mendoza
- Independent Director
- 352.73K
- Dr. Thomas E. Shenk, PhD
- Independent Director
- 347.73K
- Dr. Debra Yu, M.D.
- Independent Director
- 332.73K
- Robert J. Wollin
- General Counsel and Secretary
- --
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
